Angioplasty of femoropopliteal lesions with the paclitaxel-coated balloon proved to be superior to conventional balloon angioplasty with regard to restenosis and need for repeat revascularization t... Background Paclitaxel drug-coated balloon (DCB) catheter angioplasty is the preferred treatment for revascularization of femoropopliteal lesions in peripheral artery disease, but mortality is a saf...
Extended safety review including patients who were lost to follow-up at 2 years revealed no evidence of an increased risk of all-cause mortality after femoropopliteal drug-coated balloon angioplasty.